Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.54 |
| ▸ | ACE | P12821 | 5/20 | 0.53 |
| ▸ | CPA1 | P15085 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30122989 | 1.00 | MME (0.54) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL30839491 | 0.99 | MME (0.53) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL2228574 | 0.96 | MME (0.58) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL10715137 | 0.96 | MME (0.58) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL31031588 | 0.95 | SLC7A5 (0.56) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL29619568 | 0.95 | ENPEP (0.56) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL30123104 | 0.95 | ENPEP (0.56) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL30974501 | 0.94 | ENPEP (0.53) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL30390719 | 0.91 | MME (0.55) | MMEACECPA1ACE2SLC7A5 | |
| SCHEMBL29430160 | 0.91 | ENPEP (0.55) | MMEACECPA1ACE2SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |